The Laoui Lab will be well represented at the Tumor Heterogeneity, Plasticity and Therapy (3rd edition) conference #THPT25! Join us to hear more about therapy resistence in #cancer from Anna Obenauf
@obenaufa.bsky.social
Submit your abstract by the 8th of October on vibbio.tech/THPT25
Glad to have been part of this exciting project!
The coming 3 days, I’m conference reporter at the Immune Niches in Cancer and Inflammation conference in Bruges #INCI25 😀
Follow @laouimmunology.bsky.social, our lab accounts for the highlights!
Join us in Bruges at the #INCI25 to discuss more about novel #celltherapies to treat #cancer
Last chance to register!
🔗 vibbio.tech/INCI25
Don't forget to register for #INCI25 at vibbio.tech/INCI25
⏰Deadline: 23rd of April
Interested in hearing more about how our 🕐internal clock🕐 can influence anti-tumor immunity? Christoph Scheiermann will explain all about it at the Immune Niches in Cancer and Inflammation conference #INCI25 !
Don’t miss the early bird registration!
🚨Deadline: 26th of March
vibbio.tech/INCI25
🚨Early Bird registration deadline for #INCI25 is approaching
Register before the 26th of March and join us in Bruges to hear more from Miriam Merad on the regulation of #TLS formation and maintenance in #cancer and discuss the role of #DCs in TLS 😃
@miriammerad.bsky.social
vibbio.tech/INCI25
My abstract is submitted already, don't forget to submit yours to join us at #INCI25 in Bruges to discuss how dendritic cells can serve as cancer therapy 😀
⌛ Only three days left until the #INCI25 abstract deadline! Submit your #cancerbiology or #inflammation research by Friday, February 28.
Present your research on stage or in poster sessions to win the Cell Press Poster Prize🏆. Upload it to vibbio.tech/4gYySvZ
Join us and discover our research at #INCI25 in the wonderfull Bruges ! Submit your abstract by the 28th of February at vibbio.tech/INCI25
Today is #womaninscience day! For all the ladies out there that doubt if science is something for them, yes it is! #proudoftheteam @vubrussel @viblifesciences.bsky.social
Excited to share our latest work in @NatureComms
! 🎉 LNP-formulated mRNA encoding IL-21, IL-7, & 4-1BB drives systemic anti-tumor immunity—spotlight on cDC2s! 👀 Led by Ahmed Hamouda, in collaboration with @eTheRNA_engine
& @bruno_de_geest. Read here: rdcu.be/d2zQ7
